Women were less than half of the people tested for almost all of these common medicines.

NCT00090259

Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)

See it on ClinicalTrials.gov ↗

3,834 people

1,143 womenmiddle line = equal numbers2,691 men
Phase
PHASE3
Paid for by
Organon and Co
Finished
2009-05-13
Health conditions
Heart Failure
Who could join
Anyone
Ages
18 Years – no maximum
Average age
mean 64.2 years
Age 65+
53.9%
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
Not reported

Women left out

No rules that kept women out were found.

Study titles and rules are shown in their original English.